Neurology Minute
1,957 episodes — Page 5 of 40
September 2025 Capitol Hill Report: BrainPAC Update
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from September 8, providing important updates around BrainPAC. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Overcoming Colonialism in Pathogen Genomics
Dr. Deanna Saylor and Dr. Senjuti Saha discuss colonialism in global health and the importance of pathogen genomics. Show reference: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00091-8/fulltext
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 2
In the final episode of this two-part series, Dr. Justin Abbatemarco discusses long-term maintenance therapy options. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 1
In part one of this two-part series, Dr. Justin Abbatemarco discusses what we know and don't know surrounding MOG antibody–associated diseases (MOGADs). Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
Outcomes Following Acute Plasma Exchange for MOGAD - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Outcomes Following Acute Plasma Exchange for MOGAD - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss a long-term maintenance approach for MOGAD. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
In part two of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the future of addressing intolerable suffering in practice and explore the opportunities for MAID. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Outcomes Following Acute Plasma Exchange for MOGAD - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Safety and Efficacy of Satralizumab in Patients with Generalized MG
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
UNITE Randomized Clinical Trial
Dr. Bradley Ong discusses the efficacy and safety of fremanezumab in adults with migraine and comorbid major depressive disorder. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2833452
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss ways to empower professionals in the fields of neurology and research.
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss strategies for advancing the fields of neurology and neuroscience research.
Women History Minute - Ellen Grass
Dr. Bakhtawar Ahmad discuss Ellen Grass the founder of the Grass Instruments Company, which played a vital role in the technological development of EEG in this women history minute.
Shedding a Light on Neurodiversity
Dr. Paige Kalika discusses the importance of embracing neurodiversity in medicine. Show reference: https://jamanetwork.com/journals/jama/article-abstract/2830611
Dihydroergotamine Nasal Powder
Dr. Bradley Ong discusses a newly FDA-approved nasal powder formulation for treating debilitating migraine attacks.
Updates on All Things Myositis – Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Andrew Mammen discuss what's new in the diagnosis and treatment of dermatomyositis.
Updates on All Things Myositis – Part 1
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Andrew Mammen discuss the advancements made over the past decade regarding HMGCR antibody-associated myositis and how to treat it.
September 2025 President Spotlight: AAN Brain Health Summit
In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight this year's AAN Brain Health Summit and discuss the events taking place. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight https://www.aan.com/tools-resources/brain-health/brain-health-summit
August 2025 Capitol Hill Report: Neurology off the Hill
In the fourth episode of this series, Dr. Andy Southerland discusses the Capitol Hill Report from August 11th, where AAN members met with their local state representatives to discuss making telehealth flexibilities permanent and reforming prior authorization processes. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 2
In the final part of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss how to speak with patients and families when having a conversation about an initial diagnosis of Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
Dr. Alex Menze and Dr. Christopher J. Klein discuss whether GLP-1RA usage is linked to radiculoplexus neuropathy and common fibular neuropathy. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213916
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years - Part 1
In part one of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss what this study teaches us about the diagnosis of Parkinson disease once it is given to patients who are subsequently followed over time. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499
Foundational Neurology Series - Part 5
In the final episode of this foundational neurology series, Casey Kozak discusses serotonin syndrome.
Foundational Neurology Series - Part 4
In part four of this foundational neurology series, Casey Kozak explores neuroleptic malignant syndrome and highlights key similarities and differences with malignant hyperthermia.
Foundational Neurology Series - Part 3
In part three of this foundational neurology series, Casey Kozak discusses malignant hyperthermia caused by inhaled anesthetics and depolarizing neuromuscular blockers.
FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making
Dr. Trey Bateman and Dr. David T. Jones discuss how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213831
Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation
Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00439-8/fulltext
Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society's 67th Annual Scientific Meeting in June 2025. Show reference: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957
Foundational Neurology Series - Part 2
In part two of this foundational neurology series, Casey Kozak discusses key differences and clinical implications of subdural hematomas.
Foundational Neurology Series - Part 1
In part one of this foundational neurology series, Casey Kozak discusses how to interpret a head CT as well as the clinical presentation of epidural hematomas.
Implications for Diagnostic Criteria for Primary Lateral Sclerosis
Drs. Jeff Ratliff, Michael A. Van Es, and Eva de Boer discuss what this study taught us about the value and application of the 2020 consensus criteria for diagnosing primary lateral sclerosis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213461
Long-Term Fatigue Following Transient Ischemic Attack
Drs. BJ Hicks, Birgitte Hede Ebbesen, and Boris Modrau discuss fatigue following transient ischemic attack and examine the characteristics of patients who experience pathologic fatigue. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213605
Updates in Neuroinfectious Diseases - Part 10
In the final episode of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when and where to use clinical metagenomic next-generation sequencing tests, as well as the limitations of these tests. Show reference: https://www.nature.com/articles/s41591-024-03275-1
Updates in Neuroinfectious Diseases - Part 9
In part nine of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the findings from this study and the implications for global vaccine strategy. Show reference: https://pubmed.ncbi.nlm.nih.gov/40086461/
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss the changes that neurologists should implement in their clinics based on the findings from this study regarding APOE genotype. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 1
In part one of this two part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss what neurologists need to know about how APOE4 and amyloid interact to impact cognitive function. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Dr. Halley Alexander and Dr. Juan Luis Alcala-Zermeno discuss the outcomes of epilepsy surgery, specifically for patients with tonic-clonic seizures. Show references: https://onlinelibrary.wiley.com/doi/10.1111/epi.18243 https://onlinelibrary.wiley.com/doi/full/10.1111/epi.17452 https://directory.libsyn.com/episode/index/id/26286819
Women History Minute - Tilly Edinger
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Tilly Edinger.
August 2025 President Spotlight: Strategizing to reach the AAN's goals
In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the mid-year assessment of AAN's five-year strategic plan. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
July 2025 Capitol Hill Report: Medicare Physician Fee Schedule
In the third episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, which outlines the 2026 Medicare fee schedule proposal. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Medical Student Perspectives on Stigma in FND
Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219
Medical Student Perspectives on Stigma in FND
Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Show reference: https://www.nejm.org/doi/10.1056/NEJMoa2413449
Updates in Neuroinfectious Diseases - Part 8
In part eight of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and the potential impact on clinical practice. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2824325
Updates in Neuroinfectious Diseases - Part 7
In part seven of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss how to counsel patients about getting care abroad. Show reference: https://academic.oup.com/cid/article/78/6/1554/7280488
Updates in Neuroinfectious Diseases - Part 6
In part six of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss findings from a recent systematic review on pneumococcal meningitis, including the role of corticosteroid, the importance of treatment timing, and emerging adjunctive therapies that may improve patient outcomes. Show reference: https://academic.oup.com/braincomms/article/6/3/fcae131/7644484
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
Dr. Jason Crowell discusses clinical considerations when addressing cognitive concerns in patients with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699 https://directory.libsyn.com/episode/index/id/32642512
Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Dr. Dan Ackerman and Dr. James Ernest Siegler discuss the complexities of treating ESUS and emphasize the importance of personalized treatment approaches based on individual patient factors. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213876
Updates in Neuroinfectious Diseases - Part 5
In part five of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and when clinicians should maintain suspicion for parechovirus. Show reference: https://academic.oup.com/cid/article-abstract/79/6/1479/7726317?redirectedFrom=fulltext